Paragon Care (PGC)

Se pone interesante

https://www.google.com/finance?q=ASX%3APGC&ei=jWKjWIHlCNDRUp7ClJgL

Buenos ratios financieros

 

http://www.4-traders.com/PARAGON-CARE-LTD-10356314/financials/

What Investors Should Know About Paragon Care Limited’s (ASX:PGC) Financial Strength?
Michael Canly May 29, 2017
Paragon Care Limited (ASX:PGC) is a small-cap-stock with a market capitalization of USD $87 Million. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they end up ignoring a key aspect, which could be the biggest threat to its existence: its financial health. There are always disruptions which destabilize and many a times end an existing industry, and most small-cap companies are the first casualties when such a wave hits.

Apart from geopolitical events such as political unrest and natural calamities, a company which is suddenly facing a hostile market environment must be able to fulfil short-term commitments with its reserves so that it can see another day. Thus, it becomes utmost important for an investor to test a company’s resilience for such contingencies. In simple terms, I believe these three small calculations tell most of the story you need to know.
See our latest analysis for PGC
Does PGC generate enough cash through operations to meet all its needs?

More than the revenue shown on paper, what matters is how much cash is generated through operations and whether it is enough to continue operations, meet debt-obligations and fund growth. Over the past year, Paragon Care’s operating cash flows stood at 21.6% of its overall debt. That means Paragon Care’s core operations are generating enough cash to comfortably service its debt.


Paragon Care (ASX:PGC) Historical Debt May 29th 17

Paragon Care (ASX:PGC) Historical Debt May 29th 17

Does PGC’s cash and short-term assets cover its short-term commitments?

While failure to manage cash has been one of the major reasons behind the demise of a lot of small businesses, the mismanagement comes into the limelight during tough situations such as economic recession, war, natural disaster, sudden increase in the price of raw materials, and a supply chain risk, which can put a company in a difficult situation. However, banks, creditors, wages, and commitment to suppliers do not go away even during an extreme event. So, a company must maintain enough liquidity to meet its short-term obligations to survive. Paragon Care is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.


Paragon Care (ASX:PGC) Net Worth May 29th 17

Paragon Care (ASX:PGC) Net Worth May 29th 17

Can PGC service its debt comfortably?

While ideally I reckon the debt-to equity ratio of a financially healthy company to be less than 40%, several factors such as industry life-cycle and economic conditions can result in a company raising a significant amount of debt. For Paragon Care, the debt to equity ratio is 47.8% and this indicates that Paragon Care’s debt is at an acceptable level. No matter how high is the debt, if a company can easily cover the interest payments, it’s considered to be making a good use of that excessive leverage. To keep an eye on how it’s doing on that front, an investor can check how easily the company can service its debt. If it earns at least 5x or more of its interest payments, that’s an indication of financial strength. In PGC’s case the interest on debt is well covered by earnings (7.3x coverage).

Conclusion

Whilst Paragon Care’s debt to equity ratio is high for my liking, it’s interest costs are well covered by it’s net income and the company’s operating cash flows are strong enough to fuel it’s future growth activities or pay dividends. Overall it’s in a strong financial position.

Now when you know whether you should keep the debt in mind as a risk factor when putting together your investment thesis, I recommend you check out our latest free analysis report on Paragon Care to see what are PGC’s growth prospects and whether it could be considered an undervalued opportunity

https://simplywall.st/news/2017/05/2...cial-strength/

 

http://www.4-traders.com/PARAGON-CARE-LTD-10356314/news/Paragon-Care-DRP-Issue-Price-ndash-13-March-2017-24034233/

Financials ( AUD) <!-- table.Bord { border-collapse:collapse; font-family: arial; font-size: 12px; } table.Bord tr td { border-bottom: solid 1px #CCCCCC; padding-top:4px; padding-bottom:4px; } --> Sales 2017 118 M EBIT 2017 15,4 M Net income 2017 9,30 M Debt 2017 - Yield 2017 3,48% P/E ratio 2017 13,62 P/E ratio 2018 11,62 Capi. / Sales 2017 1,10x Capi. / Sales 2018 1,02x Capitalization 130 M More Financials

JULY 17, 2017 DBR STAFF

Paragon Care Ltd (PGC.AX) Showing Positive Momentum

 

Paragon Care Ltd (PGC.AX) shares are showing positive momentum over the past week as the stock has clocked in consecutive positive sessions over that time.  In taking a look at recent performance, we can see that shares have moved 5.70% over the past week, 12.08% over the past 4-weeks, 0.60% over the past half year and 21.40% over the past full year.

Fundamental Data
Now we’ll take a look at how the fundamentals are stacking up for Paragon Care Ltd (PGC.AX). Fundamental analysis takes into consideration market, industry and stock conditions to help determine if the shares are correctly valued.

One ratio we can look at is the Return on Invested Capital or more commonly referred to as ROIC. Paragon Care Ltd (PGC.AX) has a current ROIC of 7.79. ROIC is calculated by dividing Net Income – Dividends by Total Capital Invested.

ROIC measures how effectively company management is using invested capital to generate company income. A high ROIC number typically reflects positively on company management while a low number typically reflects the opposite.

Another key indicator that can help investors determine if a stock might be a quality investment is the Return on Equity or ROE. Paragon Care Ltd (PGC.AX) currently has Return on Equity of 11.71. ROE is a ratio that measures profits generated from the investments received from shareholders.

In other words, the ratio reveals how effective the firm is at turning shareholder investment into company profits. A company with high ROE typically reflects well on management and how well a company is run at a high level. A firm with a lower ROE might encourage potential investors to dig further to see why profits aren’t being generated from shareholder money.

Turning to Return on Assets or ROA, Paragon Care Ltd (PGC.AX) has a current ROA of 5.99. This is a profitability ratio that measures net income generated from total company assets during a given period. This ratio reveals how quick a company can turn it’s assets into profits. In other words, the ratio provides insight into the profitability of a firm’s assets. The ratio is calculated by dividing total net income by the average total assets.

A higher ROA compared to peers in the same industry, would suggest that company management is able to effectively generate profits from their assets. Similar to the other ratios, a lower number might raise red flags about management’s ability when compared to other companies in a similar sector.

Paragon Care Ltd currently has a yearly EPS of 0.05. This number is derived from the total net income divided by shares outstanding. In other words, EPS reveals how profitable a company is on a share owner basis

 

Ratios y resultados de los últimos años.

 

http://www.paragoncare.com.au/wp-content/uploads/PGC-Paragon-Care-Equity-Report-Shaw-and-Partners_v2017-07-04.pdf

Buenísimos resultados

 

http://www.paragoncare.com.au/wp-content/uploads/PGC_Full-Year-Results-Investor-Presentation-2017-08-07.pdf

07 August 2017

ASX ANNOUNCEMENT

paragoncare.com.au

Paragon Care reports record results for FY17

Melbourne, Australia - Paragon Care (ASX: PGC) (Paragon or Company) today announced its financial results for the full year ended 30 June 2017.

FY17 full year results highlights

• 
  

  Revenue of $117m, up 25% on FY16 driven by strong second half performance

  
  


• 
  

  EBITDA of $17.1m, up 41% on FY16 with record EBITDA margins of 14.7%

  
  


• 
  

  Earnings per share of 6.2 cents, up 11%

  
  


• 
  

  Total FY17 dividends of 3.0 cents per share, up 36% on FY16

  
  


• 
  

  Results reflect organic EBITDA growth at 15% for the year underpinned by strong progress realising revenue and cost synergies from recent acquisitions

  
  


• 
  

  Strong balance sheet with $18.6m cash and 1.1x Net Debt / EBITDA at 30 June 2016 ensures that Paragon is well positioned for future growth

  
  

Nuevo tirón al alza y toca los 94 c.

 

http://www.google.com/finance?q=ASX%3APGC&ei=VwSKWdnfHMGxsgHJ37zYDQ

Paragon surges, with more upside possible

Published on: Aug 9, 2017 | by Trevor Hoey

Shares in healthcare equipment group, Paragon Care (ASX: PGC) spiked from Friday’s close of 81 cents to hit an intraday high of 93 cents on Monday. This occurred under the highest daily volumes recorded in the last five years. The intraday high was repeated again on Tuesday.

It should be noted share trading patterns should not be used as the basis for an investment as they may or may not be replicated. Those considering this stock should seek independent financial advice.

Interestingly, the provider of medical equipment, devices and consumables to the health care industry has traded as high as 94 cents during its circa 10 year history as an ASX listed entity, and it could be technical selling that is currently keeping a lid on the company’s share price.

Certainly, the result appeared to warrant a rerating as the impressive key financials below indicate.

While revenues were broadly in line with management’s guidance, there was a slight outperformance at the EBITDA line.

Brokers see further upside

As indicated by John Hester from Bell Potter, PGC is best assessed on its earnings per share performance. As a growth by acquisition story, the company has issued new shares over the last two years, effectively diluting earnings per share.

Consequently, using this measure takes into account the impact of issuing scrip for all or part consideration in relation to acquisitions.

Bell Potter is forecasting earnings per share to increase to 6.9 cents in fiscal 2018, implying a PE multiple of 13.4 relative to its 12 month high of 93 cents. This represents a 50% discount to the broader sector average PE multiple of 26.8.

Of course broker projections and price targets are only estimates and may not be met.

However, some of the larger blue-chip companies tend to push the average multiple higher than what is normally representative of the mid-tier players.

The broker reactions have been interesting with Bell Potter maintaining its buy recommendation and slightly increasing its price target to $1.02.

By contrast, Ian Christie from Argonaut views the current price as good value with his valuation of $1.12 implying upside of 20% to the group’s current trading range. He expects PGC to achieve organic growth of 10% per annum over the next two years with EBITDA margins of circa 15%.

Again, broker projections should only be taken into account with all publically available information.

PGC’s Managing Director, Mark Simari was relatively upbeat with his outlook statement, saying that the company is well-placed to deliver growth in future years, driven by a combination of organic and acquisitive growth with the e-health sector offering a new revenue stream.

The addition of services and maintenance contracts will also help, as they provide recurring income to complement revenues generated from the sale of new equipment.

Paragon Care : Acquisition of Medtek Pty Ltd

 

0

08/14/2017 | 05:52am CEST

Send by mail :

Last Name : Name : From* : To* : (You can enter multiple email addresses separated by commas) Message : *Required fields

14th August 2017

Australian Securities Exchange Company Announcements Office

ACQUISITION OF MEDTEK

ASX ANNOUNCEMENT

paragoncare.com.au

The Directors of Paragon Care Limited (ASX: PGC) ("Paragon" or the "Company") are pleased to announce the agreed acquisition of Medtek Pty Ltd ("MTK") for a purchase consideration of $649,000 to be funded via Paragon shares and cash.

Medtek focuses on the Far North Queensland region and specialises in providing high-quality biomedical engineering services and preventative maintenance to the Medical, Scientific, Aged Care and Allied Health clientele in the region.

With offices in Cairns and Townsville, the acquisition allows Paragon to penetrate the region with direct representation, expand its service and maintenance offering and establish a sales gateway for the balance of its product portfolio.

Highlights:

• Acquisition of Medtek for $649,000

• Paragon will leverage Medtek's Far North Queensland penetration via its offices in Cairns and Townsville

• EPS accretive in FY18

Following the acquisition, and when combined with Paragon's existing service and maintenance operations, the Company will have in excess of 50 biomedical engineers and service technicians servicing the Australian and New Zealand healthcare sector. This will provide a solid foundation for growth for FY18 and beyond as Paragon fulfils an element of its strategic plan in providing a high quality national service and maintenance offering to its clients.

The transaction albeit not material in terms of additional sales and profit will be modestly EPS accretive in FY18. The consideration of $649K for Medtek includes $50,000 in Paragon fully paid ordinary shares with the balance in cash.

The Managing Director, Mark Simari commented, "The Medtek acquisition strengthens Paragon's Far North Queensland representation, whilst generating significant sales gateways for the future."

John Osborne

Company Secretary

For further information please contact: Mark Simari - Managing Director

T: 1300 369 559 E: [email protected]

About Paragon Care Limited

Paragon Care is a Melbourne based, listed company with the ASX (PGC), which has progressively acquired businesses in the healthcare sector. It is a leading provider of medical equipment, devices and consumables for the Australian and New Zealand healthcare market. These are high growth markets driven by the ageing of the population, continuously rising consumer expectations and increasing government spending. By combining a series of strategic acquisitions of class leading companies, Paragon Care has positioned itself to provide end to end solutions including equipment and consumable solutions for acute, aged, primary, community and hospital care. Paragon Care Ltd.'s head office is located at 11 Dalmore Drive Scoresby VIC 3179 Australia. For further information please contact Mark Simari, Managing Director (1300 369 559) or via email at [email protected].

 

http://www.4-traders.com/PARAGON-CARE-LTD-10356314/news/Paragon-Care-Acquisition-of-Medtek-Pty-Ltd-24940932/

Interesante video analizando Paragon Care

 

 

https://www.youtube.com/watch?v=o2vXJiDA6R0&spfreload=10

https://simplywall.st/news/2017/08/30/should-income-investors-buy-paragon-care-limited-asxpgc-before-its-ex-dividend/